Beleave Approval to Cultivate Cannabis Highlighted on Financial Post

Beleave’s (CNSX:BE) Health Canada approval to cultivate cannabis was spotlighted on Financial Post. According to the article, “Five months ago, publicly traded medical marijuana companies already had a combined market value of $3 billion, but the legalization of recreational marijuana could expand their revenue significantly. Last year, CIBC World Markets predicted that legalized recreational marijuana could become a $10-billion-a-year industry; other analysts put that number even higher.”
Click here to read the full article.
Click here to connect with Beleave (CNSX:BE) to receive an Investor Presentation.